AKT1 and gout: Clinical research has demonstrated that the Huangqin Qingrechubi capsule significantly enhances lipid metabolism disorders and inflammatory responses in patients with gouty arthritis by modulating the lncRNA H19/APN/PI3K/AKT pathway, thereby effectively mitigating gout symptoms (134).